Invesco Bloomberg Pricing Power ETF(POWA.US)

Company Encyclopedia
View More
name
Invesco Bloomberg Pricing Power ETF
POWA.US
News
View More

Key facts: Google contests India's security rules; Walmart partners with Alphabet

Google is challenging India's proposed security rules that require access to source code and major software changes, claiming these demands lack global precedent and threaten proprietary data.1Walmart has teamed up with Alphabet to use Google's Gemini platform, enhancing customer shopping with personalized recommendations and smoother transitions from product discovery to purchase.23Major retailers like Kroger and Lowe's are adopting Google's AI shopping agents, with Kroger testing a personalized grocery assistant and Lowe's using it for their virtual shopping tool, Mylow.4

TradingView·
US
WMT
+1.29%
TradingView·
US
WMT
+1.29%

KLA Corporation - Sticky MOAT Is The Best Type

KLA Corporation has reported strong earnings and raised guidance, positioning itself as a long-term winner in the semiconductor industry due to its "sticky" MOAT. The company boasts high switching costs for customers, making it difficult for them to switch to competitors. KLA holds a significant market share in semiconductor process controls and maintains high gross margins. Despite competition from companies like Applied Materials and ASML, KLA's extensive patent portfolio and consistent R&D investment support its growth. The company expects to continue its momentum with a price target of $1555 by 2029, reflecting a CAGR of 12.2%.

GuruFocus·
US
KLAC
+5.69%
US
SOXL
+8.66%
GuruFocus·
US
KLAC
+5.69%
US
SOXL
+8.66%

Accenture PLC Cl A Stock Outperforms Competitors On Strong Trading Day

Accenture PLC Cl A (ACN) shares rose 2.86% to $281.82 on a strong trading day, outperforming competitors like IBM, ADP, and Cognizant. The S&P 500 Index increased by 0.01%, while the Dow Jones Industrial Average rose by 0.55%. Despite the gains, Accenture's stock remains 29.25% below its 52-week high of $398.35 reached on February 5th. Trading volume was 5.2 million, surpassing the 50-day average of 3.8 million.

Dow Jones·
US
ACN
-0.41%
Dow Jones·
US
ACN
-0.41%

Regeneron Just Moved From Underperform To Buy - Here's Why

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) has been upgraded from Underperform to Buy by Bank of America (BofA) Securities, with a price forecast increase from $627 to $860. This shift is driven by higher sales expectations for key products, particularly Eylea HD, and positive developments in their pipeline. Analysts predict U.S. Eylea franchise revenues of $4.35 billion by 2026. The stock rose 4.60% to $812.27, reaching a new 52-week high, amid optimism from potential upcoming catalysts and favorable regulatory discussions.

benzinga_article·
US
REGN
-0.56%
benzinga_article·
US
REGN
-0.56%

BUZZ-Regeneron Pharma gains as BofA upgrades rating

Shares of drugmaker Regeneron Pharmaceuticalsup 3.7% at $805.32BofA Global Research upgrades rating to “buy” from “underperform”; raises PT to $860 from $627New PT represents ~11% upside to stock’s last closeBrokerage views newer version of eye drug Eylea SD to be more positive in light of label updates“We see meaningful upside from Dupixent and late-stage pipeline assets entering 2026” — BofAStock up 8.4% in 2025

Reuters·
US
REGN
-0.56%
Reuters·
US
REGN
-0.56%
© 2026 Longbridge｜Disclaimer